Jefferies Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Jefferies Group’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,900	Closed	-$202K	–	2737
2014 Q2	$202K	Sell	1,900 -41,700	-96%	-$4.09M	﹤0.01%	1755
2014 Q1	$3.79M	Buy	43,600 +4,200	+11%	+$324K	0.04%	396
2013 Q4	$1.66M	Buy	39,400 +21,300	+118%	+$876K	0.01%	629
2013 Q3	$796K	Buy	+18,100	New	+$749K	0.01%	1011

Jefferies Group's FURX Position: Q3 2014 in Review

Jefferies Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 31 shares — an estimated $3K sold.

Jefferies Group first reported a position in FURX in Q3 2013 and held it in 4 quarters. The position peaked at $3K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

Jefferies Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
Jefferies Group sold 31 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $3K.
Jefferies Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
Jefferies Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3K in Q2 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Jefferies Group's 13F filing for Q3 2014, filed 17 Nov 2014.